Related Experiment Video
Updated: Aug 13, 2026
07:30
Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery
Published on: May 4, 2022
Cervical nodal metastases of unknown origin
The Laryngoscope
|April 1, 1981
Summary
For squamous cell carcinoma metastatic to the neck, survival was 40% at three years, with combined therapy effective for larger nodes. Adenocarcinoma metastases were uniformly fatal despite treatment.
Area of Science:
- Oncology
- Head and Neck Cancer Research
Background:
- Metastatic carcinoma of unknown primary (CUP) to the neck presents a diagnostic and therapeutic challenge.
- Understanding the behavior of different histologies and nodal stages is crucial for treatment planning.
Observation:
- A study included 48 patients with metastatic carcinoma in the neck from an unknown primary.
- Patients with squamous cell carcinoma (SCC) had a 3-year survival rate of 40%.
Findings:
- SCC tumor response varied by nodal stage: similar response to surgery or irradiation for N1 nodes, but combined therapy was effective for N2/N3 nodes.
- Discovery of the primary tumor did not impact survival.
- Adenocarcinoma metastatic to cervical lymph nodes, particularly in the supraclavicular fossa, showed a uniformly poor prognosis with no effective treatment modalities.
- Nodal stage did not correlate with survival in SCC patients.
Implications:
- Treatment strategies for SCC neck metastases should consider nodal stage, with combined approaches potentially beneficial for advanced disease.
- The dismal prognosis of adenocarcinoma metastases highlights the need for novel therapeutic strategies.
- Further research into the biology of unknown primary tumors is warranted.
